...
首页> 外文期刊>Hormone molecular biology and clinical investigation. >Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal women
【24h】

Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal women

机译:选择孕激素对子宫内膜的保护结合经皮的雌二醇绝经期妇女

获取原文
获取原文并翻译 | 示例
           

摘要

Hormone therapy (HT) is indicated for the treatment of vasomotor symptoms (VMS) and the genitourinary syndrome of menopause caused by reduced estrogen levels. HT helps prevent osteoporosis, colorectal cancer, type 2 diabetes mellitus and possibly also coronary heart disease and Alzheimer's disease if started early in the perimenopause or postmenopause ("window of opportunity"); it can also have a positive effect on quality of life [1], [2], [3], [4], [5], [6].
机译:激素治疗(HT)表示血管舒缩性症状(vm)和待遇泌尿生殖器的更年期综合征所致雌激素水平降低。骨质疏松、结肠直肠癌、2型糖尿病也可能和冠心病,如果开始早期阿尔茨海默氏症准更年期或绝经后期(“窗口机会”);在生活质量[1],[2],[3],[4],[5],[6]。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号